0 139

Cited 0 times in

Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC

DC Field Value Language
dc.date.accessioned2023-06-02T01:17:24Z-
dc.date.available2023-06-02T01:17:24Z-
dc.date.issued2022-04-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194795-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleUpdated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorB.C. Cho-
dc.contributor.googleauthorC-H. Chiu-
dc.contributor.googleauthorE. Massarelli-
dc.contributor.googleauthorS.P. Chawla-
dc.contributor.googleauthorG.L. Buchschacher Jr.-
dc.contributor.googleauthorK. Goto-
dc.contributor.googleauthorS-W. Kim-
dc.contributor.googleauthorT.R. Overbeck-
dc.contributor.googleauthorH.H.F. Loong-
dc.contributor.googleauthorC.E. Chee-
dc.contributor.googleauthorP. Garrido-
dc.contributor.googleauthorS. Heinzmann-
dc.contributor.googleauthorB. Pitcher-
dc.contributor.googleauthorT. John-
dc.identifier.doi10.1016/j.annonc.2022.02.137-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422002538-
dc.citation.volume33-
dc.citation.numbersuppl 2-
dc.citation.startPageS82-
dc.citation.endPageS83-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(suppl 2) : S82-S83, 2022-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.